News & Updates

In early to mid-pregnancy, low or excessively high maternal serum folate levels carry a heightened risk of congenital heart disease (CHD) in the offspring, as shown in a study.

New drug applications approved by US FDA as of 1-15 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

High sperm deoxyribonucleic acid fragmentation index (DFI) level appears to negatively affect the outcome of pregnancies achieved with assisted reproductive technology (ART), being linked to increased risks of complications such as preterm birth and pre-eclampsia in a new research.

Treatment with fuzuloparib, with or without apatinib, significantly improved progression-free survival (PFS) in patients with HER2– metastatic breast cancer (mBC) harbouring germline BRCA1/2 (gBRCA1/2) mutations compared with standard chemotherapy, according to results of a phase III study presented at ESMO 2024.

A prospective cohort study has linked prenatal use of aspirin to better neurocognitive development in offspring.

Hypertension, regardless of blood pressure control, appears to exert a negative influence on fecundability in women, as reported in a study.